pharma · Hemophilia A · Hemophilia A or B With Inhibitors
Baxalta Innovations
Baxalta Innovations GmbH
Baxalta Innovations patent portfolio — 1 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Illinois, USA HQ
2015 Founded
475 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- Illinois, USA
- Founded
- 2015
- Employees
- 475
- Programs
- 6
- Drugs
- 12
- Patents
- 1
Baxalta Innovations patents
1 pharmaceutical patents indexed for Baxalta Innovations. 0 expire within 24 months.
Baxalta Innovations has 1 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
Patent portfolio
Frequently asked questions
How many patents does Baxalta Innovations have?
1 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Baxalta Innovations patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.